Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines
about
Angiopoietin-like protein 4: health effects, modulating agents and structure-function relationshipsGenomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signalingLigand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicitiesPPARβ Regulates Liver Regeneration by Modulating Akt and E2f Signaling.Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells.Establishing the Role of PPARβ/δ in CarcinogenesisSorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.PPAR Agonists for the Prevention and Treatment of Lung Cancer.Platelet-targeted pharmacologic treatments as anti-cancer therapy.Peroxisome proliferator-activated receptor {delta} activators induce IL-8 expression in nonstimulated endothelial cells in a transcriptional and posttranscriptional manner.Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention.
P2860
Q28263229-582B03D7-5E43-4FD3-828F-F66E29A8FC8BQ28476779-1EF089BE-4384-4020-B876-8A1ADFFC704CQ33594693-9DDE3B20-0BAB-46A0-9D2A-0078DC5D65ADQ33625872-A62FEEC1-361C-4E02-8BD0-44F7F9386F4FQ33931176-5622F1F2-27AB-42DF-BEFC-B0D8DF9B6716Q34128015-AB7B8198-F3C7-4D18-B026-DDE278A5A795Q34625038-79A6CAE7-81FF-4A92-8BA4-D2F8606867ADQ34792575-23EE7882-F760-4296-849D-121F675A18DDQ35613331-D38FE462-43E4-4C54-9F84-E9D3C779FD26Q36023224-216E94FC-C812-453E-83A6-7BE6661C159DQ36244704-286EFB7B-C60E-41BC-8547-E7E56FE7BC0FQ37388607-DF9836BF-335F-4633-B068-C6943D6F5514Q37681630-0CEEBB6C-2D10-4B96-AE54-C6AE28CBEE03Q38657846-CFA974D6-3020-4E69-B10D-AEE245748EE9Q42400879-12787A24-3FD1-4C88-BA7C-D968C22897EEQ42551493-75E1262D-4624-458B-B643-F7EF26A68E2E
P2860
Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of ligand activation of ...... n human lung cancer cell lines
@en
Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta
@nl
type
label
Effect of ligand activation of ...... n human lung cancer cell lines
@en
Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta
@nl
prefLabel
Effect of ligand activation of ...... n human lung cancer cell lines
@en
Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta
@nl
P2093
P2860
P1433
P1476
Effect of ligand activation of ...... n human lung cancer cell lines
@en
P2093
Arun K Sharma
Frank J Gonzalez
Karam El-Bayoumy
Michael G Borland
Pengfei He
Shantu Amin
P2860
P304
P356
10.1016/J.TOX.2008.09.023
P407
P577
2008-10-02T00:00:00Z